Study to confirm clinical benefit of Silk Vista and Silk Vista Baby in a wide range of anatomical locations BOSTON, July 28, 2021 (GLOBE NEWSWIRE) — Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating […]

MONTMORENCY, France–(BUSINESS WIRE)–Balt (www.balt-corp.com) announced today it has received CE Mark Approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms, enabling commercialization in over 30 countries in and around the European Union. Flow diverters […]